Prescription of hormone replacement therapy in postmenopausal women with renal failure

Kidney International

Volumn 56, Issue 6, 1999, Pages 2243-2247

  Stehman Breen, Catherine O ^a,b,c   Gillen, Daniel ^a,b   Gipson, Debbie ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Puget Sound Health Care System   (United States)

Author keywords

Cardiovascular disease; ESRD; Hormone prescription; Menopause; Women

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNOLOGY; FEMALE; HORMONE SUBSTITUTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 0033452104     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00793.x     Document Type: Article

References (25)

1. 1. Ettinger B, Genant H, Cann C: Long-term estrogen replacement therapy prevents bone loss and fractures. N Engl J Med 102:319-324, 1985
2. 2. Hovik P, Sundsbak H, Gasemyr M, Sandvik L: Comparison of continuous and sequential oestrogen-progesterone treatment in women with climacteric symptoms. Maturitas 11:75-82, 1989
3. 3. Naessen T, Persson I, Adami H: Hormone replacement therapy and the risk of first hip fracture: A prospective, population-based cohort study. Ann Intern Med 113:95-103, 1990
4. 4. Yaffe K, Sawaya G, Lieberburg I, Grady D: Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 279:688-695, 1998
5. 5. Writing group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208, 1995
6. 6. Grady D, Rubin S, Petitti D, Fox C, Black D, Ettinger B, Ernster V, Cummings S: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037, 1992
7. 7. Stamper M, Colditz G: Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63, 1991
8. 8. Wysowski D, Golden L, Burke L: Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 85:6-10, 1995
9. 9. Collins K, Schoen C, Joseph S, Duchon L, Simantov E, Yellowitz M: Health Concerns Across a Woman's Lifespan: The Commonweath Fund 1998 Survey of Women's Health. New York, The Commonwealth Fund, 1999
10. 10. Owen W, Madore F, Brenner B: An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis 28:931-936, 1996
11. 11. Stein M, Packham D, Ebeling P, Ward J, Becker G: Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28:515-522, 1996
12. 12. Erlichman M, Holohan T: Bone densitometry: Patients with end stage renal disease. Health Technol Assess 8:1-27, 1996
13. 13. Sehgal A, Grey S, Deoreo P, Whitehouse P: Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 30:41-49, 1997
14. 14. Holley J, Schmidt R, Bender F, Dumler F, Schiff M: Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29:685-690, 1997
15. 15. US Renal Data System: USRDS 1998 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1998
16. 16. McNagny S, Wenger N, Frank E: Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Ann Intern Med 127:1093-1096, 1997
17. 17. Hemminki E, Brambilla D, McKinlay S, Posner J: Use of estrogens among middle-aged Massachusetts Women. Ann Pharmacother 25:418-423, 1991
18. 18. Barret-Connor E: Lower endogenous androgen levels and dyslipidemia in men with non-insulin dependent diabetes mellitus. Ann Intern Med 117:807-811, 1992
19. 19. Handa V, Landerman R, Hanlon J, Harris T, Cohen H: Do older women use estrogen replacement? Data from the Duke established-populations for epidemiologic studies of the elderly (EPESE). J Am Geriatr Soc 44:1-6, 1996
20. 20. Cauley J, Seeley D, Ensrud K, Ettinger B, Black D, Cummings S: Estrogen replacement therapy and fractures in older women: Study of Osteoporotic Fractures Research Group. Ann Intern Med 122:9-16, 1995
21. 21. Harris R, Laws A, Reddy V, King A, Haskeel W: Are women using postmenopausal estrogens? A community survey. Am J Public Health 80:1266-1268, 1990
22. 22. Ferguson K, Hoegh C, Johnson S: Estrogen replacement therapy: A survey of women's knowledge and attitudes. Arch Intern Med 149:133-136, 1989
23. 23. Salamone L, Pressman A, Seeley D, Cauley J: Estrogen replacement therapy: A survey of older women's altitude. Arch Intern Med 156:1293-1297, 1996
24. 24. McNagy S, Jacobson T: Use of postmenopausal hormone replacement therapy by African American women. Arch Intern Med 157:1337-1342, 1997
25. 25. Couley J, Cummings S, Black D, Mascioli S, Seeley D: Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 163:1438-1444, 1990